Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Sales | 9,680 | 7,314 | 5,923 | 4,761 | 4,769 |
| Cost of Goods | 4,556 | 4,267 | 4,081 | 3,923 | 4,640 |
| Gross Profit | 5,124 | 3,047 | 1,842 | 838 | 129 |
| Operating Expenses | 9,156 | 8,568 | 8,652 | 8,068 | 5,851 |
| Operating Income | -3,476 | -5,254 | -6,729 | -6,307 | -5,082 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | 30 | 110 | 29 | 145 | 372 |
| Pre-tax Income | -3,446 | -5,144 | -6,700 | -6,162 | -4,711 |
| Net Income Continuous | -3,446 | -5,144 | -6,700 | -6,162 | -4,711 |
| Net Income | $-3,446 | $-5,144 | $-6,700 | $-6,162 | $-4,711 |
| EPS Basic Total Ops | -0.50 | -0.80 | -1.20 | -1.10 | -0.90 |
| EPS Basic Continuous Ops | -0.51 | -0.77 | -1.21 | -1.12 | -0.86 |
| EPS Diluted Total Ops | -0.50 | -0.80 | -1.20 | -1.10 | -0.90 |
| EPS Diluted Continuous Ops | -0.51 | -0.77 | -1.21 | -1.12 | -0.86 |
| EBITDA(a) | $-3,262 | $-5,087 | $-6,620 | $-6,210 | $-5,067 |